Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 Influenza Season

For the 2017–18 season, quadrivalent and trivalent influenza vaccines will be available. Inactivated influenza vaccines (IIVs) will be available in trivalent (IIV3) and quadrivalent (IIV4) formulations. Recombinant influenza vaccine (RIV) will be available in trivalent (RIV3) and quadrivalent (RIV4) formulations. Live attenuated influenza vaccine (LAIV4) is not recommended for use during the 2017–18 season due to concerns about its effectiveness against (H1N1)pdm09 viruses during the 2013–14 and 2015–16 seasons. Recommendations for different vaccine types and specific populations are discussed. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is available.

• Publication year

  2017

• Venue

  American Journal of Transplantation

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ajt.14511PMID 29083555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial

  2017cited by this paper
• Influenza

  2017cited by this paper
• Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

  2017cited by this paper
• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017

  2017cited by this paper
• General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (Acip)

  2016cited by this paper
• Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015

  2016cited by this paper
• Febrile Seizure Risk After Vaccination in Children 6 to 23 Months

  2016cited by this paper
• Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons

  2016cited by this paper
• Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

  2015cited by this paper
• Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy

  2015cited by this paper
• Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.

  2015cited by this paper
• Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.

  2015cited by this paper
• Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.

  2015cited by this paper
• Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.

  2015cited by this paper
• Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.

  2014cited by this paper
• 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

  2014cited by this paper
• Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

  2014cited by this paper
• Prevention of Serious Events in Adults 65 Years of Age or Older: A Comparison Between High-dose and Standard-dose Inactivated Influenza Vaccines

  2014cited by this paper
• Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

  2013cited by this paper
• Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.

  2013cited by this paper
• Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.

  2013cited by this paper
• Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia.

  2013cited by this paper
• The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.

  2013cited by this paper
• High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season.

  2013cited by this paper
• Influenza Vaccination Coverage Among Health-Care Personnel — United States, 2012–13 Influenza Season

  2013cited by this paper
• Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults

  2012cited by this paper
• IMMUNIZATION OF HEALTH-CARE PERSONNEL: RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

  2011cited by this paper
• Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months

  2011cited by this paper
• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2011cited by this paper
• A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.

  2011cited by this paper
• Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.

  2010cited by this paper
• Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.

  2010cited by this paper
• Recommendations for the administration of influenza vaccine in children allergic to egg

  2009cited by this paper
• A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.

  2009cited by this paper
• Influenza vaccination of healthcare personnel.

  2009cited by this paper
• Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

  2008cited by this paper
• Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age

  2008cited by this paper
• Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003–2004 and 2004–2005 Influenza Seasons

  2008cited by this paper
• Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older

  2007cited by this paper
• Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.

  2007cited by this paper
• Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

  2006cited by this paper
• Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.

  2006cited by this paper
• Influenza virus infection in travelers to tropical and subtropical countries.

  2005cited by this paper
• Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses

  2005cited by this paper
• Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory.

  2003cited by this paper
• Cruise ships: high-risk passengers and the global spread of new influenza viruses.

  2000cited by this paper
• Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time.

  1996cited by this paper
• Evaluation of the Efficacy of Split‐Product Trivalent A(H1N1), A(H3N2), and B Influenza Vaccines

  1986cited by this paper
• Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.

  1982cited by this paper
• Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary.

  1977cited by this paper
• Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity.

  1977cited by this paper
• From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II.

  1976cited by this paper
• Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.

  1976cited by this paper
• Morbidity and Mortality Weekly Report Influenza Vaccination of Health-care Personnel Recommendations of the Healthcare Infection Control Practices Advisory Committee (hicpac) and the Advisory Committee on Immunization Practices (acip)

  year unknowncited by this paper

• Influenza burden among chronic condition and immunocompromised patients in the United States

  2025cites this paper
• Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018

  2024cites this paper
• Integrating single-cell RNA sequencing data to genome-wide association analysis data identifies significant cell types in influenza A virus infection and COVID-19.

  2023cites this paper
• Determinants of parental seasonal influenza vaccine hesitancy in the Eastern Mediterranean region: A cross-sectional study

  2023cites this paper
• The issue of vaccine refusal: the study of a risky behavior

  2023cites this paper
• Food Allergy.

  2023cites this paper
• Revisiting live attenuated influenza vaccine efficacy among children in developing countries.

  2023cites this paper
• Cost-effectiveness of routine annual influenza vaccination by age and risk status.

  2023cites this paper
• Advances in Adjuvanted Influenza Vaccines

  2023cites this paper
• Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand

  2023cites this paper
• Next generation live-attenuated influenza vaccine platforms

  2022cites this paper
• Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

  2022cites this paper
• Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic

  2022cites this paper
• Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors

  2022cites this paper
• Vital sign predictors of severe influenza among children in an emergent care setting

  2022cites this paper
• Nano/microparticle Formulations for Universal Influenza Vaccines

  2022cites this paper
• Surgical mask wearing behaviour in COVID-19 pandemic and influenza seasons: a cross-sectional study on healthcare professional students and staff’s perspective in Southern California

  2022cites this paper
• El cardiólogo en la vacunación antigripal de los pacientes con cardiopatías en España

  2022cites this paper
• Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?

  2022cites this paper
• Influenza Vaccination Effectiveness in Paediatric ‘Healthy’ Patients: A Population-Based Study in Italy

  2022cites this paper
• Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16

  2022cites this paper
• Comparison of quality metrics in an education-centered medical home with local and national benchmarks

  2022cites this paper
• Parents' knowledge, attitude and practice towards seasonal influenza vaccination in Riyadh region, Saudi Arabia.

  2022cites this paper
• [Effectiveness of influenza vaccine in preventing severe influenza].

  2022cites this paper
• Impact of rotavirus vaccination on seizure hospitalizations in children: A systematic review.

  2022cites this paper
• The main directions of non-specific prevention of infectious diseases

  2021cites this paper
• Improving influenza and pneumococcal vaccination uptake among incident peritoneal dialysis patients: a quality improvement initiative

  2021cites this paper
• Machine learning models to identify low adherence to influenza vaccination among Korean adults with cardiovascular disease

  2021cites this paper
• Interventions on health care providers to improve seasonal influenza vaccination rates among patients: a systematic review and meta-analysis of the evidence since 2000

  2021cites this paper
• Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study

  2021cites this paper
• Interventions on health care providers to improve seasonal influenza vaccination rates among patients: a systematic review and meta-analysis of the evidence since 2000

  2021cites this paper
• Antigenic characterization of influenza and SARS-CoV-2 viruses

  2021cites this paper
• Gripe y eventos cardiorrespiratorios: una revisión clínico-epidemiológica multidisciplinary

  2021cites this paper
• Burden of influenza hospitalization among high-risk groups in the United States

  2021cites this paper
• Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey

  2021cites this paper
• The impact of social distancing during the COVID-19 pandemic on rates of pediatric idiopathic intussusception

  2021cites this paper
• Influenza Complicating Delivery Hospitalization and Its Association With Severe Maternal Morbidity in the United States, 2000–2018

  2021cites this paper
• Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis

  2021cites this paper
• Seasonal trends of Influenza in Islamabad, Pakistan

  2021cites this paper
• Trends, Uptake, and Predictors of Influenza Vaccination Among Healthcare Practitioners During the COVID-19 Pandemic Flu Season (2020) and the Following Season (2021) in Saudi Arabia

  2021cites this paper
• Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant.

  2021cites this paper
• Economics of Implementing Preemptive School Closures to Mitigate Pandemic Influenza Outbreaks of Differing Severity in the United States

  2021cites this paper
• A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan.

  2021cites this paper
• Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community‐dwelling adults aged ≥ 65 years in Thailand: Findings from a two‐year prospective cohort study

  2021cites this paper
• Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.

  2021cites this paper
• Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives

  2021cites this paper
• Causes, characteristics, and patterns of prolonged unplanned school closures prior to the COVID-19 pandemic—United States, 2011–2019

  2021cites this paper
• Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults >= 65 years of age: a Phase II, open-label study

  2021cites this paper
• Enhanced generation of influenza-specific tissue resident memory CD8 T cells in NK-depleted mice

  2021cites this paper
• Paninvasion severity assessment of a U.S. grape pest to disrupt the global wine market

  2021cites this paper
• Effect of race and ethnicity on influenza vaccine uptake among older US Medicare beneficiaries: a record-linkage cohort study.

  2021cites this paper
• Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge

  2020cites this paper
• Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.

  2020cites this paper
• Influenza vaccination medical waivers among healthcare workers at an academic health system

  2020cites this paper
• Knowledge and Beliefs towards Universal Safety Precautions to flatten the curve during Novel Coronavirus Disease (nCOVID-19) Pandemic among general Public in India: Explorations from a National Perspective

  2020cites this paper
• Live Attenuated Cold-Adapted Influenza Vaccines.

  2020cites this paper
• History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study

  2020cites this paper
• Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA Protein

  2020cites this paper
• The focus and timing of COVID-19 pandemic control measures under healthcare resource constraints

  2020cites this paper
• ¿Cuándo debemos vacunarnos ante la gripe estacional?

  2020cites this paper
• Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.

  2020cites this paper
• Removing the handle of the Broad Street pump: measures to slow the spread of covid-19 in primary care teams

  2020cites this paper
• Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018

  2020cites this paper
• Epidemiology of Influenza among patients with influenza‐like illness and severe acute respiratory illness in Pakistan: A 10‐year surveillance study 2008‐17

  2020cites this paper
• Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors

  2020cites this paper
• Factors associated with referring close contacts to an app with individually-tailored vaccine information.

  2020cites this paper
• Tetanus, Diphtheria, and Acellular Pertussis and Influenza Vaccinations among Women With a Live Birth, Internet Panel Survey, 2017-2018

  2020cites this paper
• Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis

  2020cites this paper
• Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics

  2020cites this paper
• Vaccine hesitancy and influenza beliefs among parents of children requiring a second dose of influenza vaccine in a season: An American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) study

  2020cites this paper
• Sensitive detection of influenza a virus based on a CdSe/CdS/ZnS quantum dot-linked rapid fluorescent immunochromatographic test.

  2020cites this paper
• Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation

  2020cites this paper
• Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes

  2020cites this paper
• Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines

  2020cites this paper
• Food Allergy: A Review.

  2020cites this paper
• Latent Class Analysis of Maternal Vaccine Attitudes and Beliefs

  2020cites this paper
• Recommended Adult Immunization Schedule, United States, 2020*

  2020cites this paper
• Prevalence and associated factors of influenza vaccination coverage in Korean adults with cardiovascular disease

  2020cites this paper
• Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China

  2020cites this paper
• BPCO

  2020cites this paper
• Quelles vaccinations sont obligatoires et recommandées chez le personnel soignant ?

  2020cites this paper
• Why are influenza vaccination coverage rates still too low among health care workers in a tertiary care children’s hospital in Turkey?

  2020cites this paper
• Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa

  2020cites this paper
• When should we get vaccinated against seasonal flu?

  2020cites this paper
• Vaccine-Preventable Diseases

  2020cites this paper
• Use of Public Data to Describe COVID-19 Contact Tracing in China during January 20-February 29, 2020

  2020cites this paper
• How health systems approached respiratory viral pandemics over time: a systematic review

  2020cites this paper
• Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”

  2020cites this paper
• Protocol for a scoping review to identify and map intervention components of existing school-based interventions for the promotion of physical activity and cardiorespiratory fitness among school children aged 6–10 years old

  2020cites this paper
• Risk conditions in children hospitalized with influenza in Norway, 2017–2019

  2020cites this paper
• Serum Vitamin D and Immunogenicity of Influenza Vaccination in the Elderly.

  2020cites this paper
• History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study

  2020cites this paper
• Characteristics of Repeated Influenza Vaccination Among Older U.S. Adults.

  2020cites this paper
• Preliminary data of a preschool teacher-screening checklist for autism spectrum disorder in Singapore

  2020cites this paper
• Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity

  2020cites this paper
• Trends in Childhood Influenza Vaccination Coverage, United States, 2012-2019

  2020cites this paper
• Factors associated with influenza vaccine noncompliance at a Rural Texas University

  2020cites this paper
• Routine Childhood Vaccines Given From 1 through 18 Years of Age.

  2020cites this paper
• A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.

  2020cites this paper
• Current Knowledge of Vaccinations in Chronic Kidney Disease Patients

  2020cites this paper